NCT02618759View on ClinicalTrials.gov

Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis

PHASE3CompletedINTERVENTIONAL

Enrollment

119

Participants

Timeline

Start Date

August 28, 2015

Primary Completion Date

March 16, 2017

Study Completion Date

August 25, 2017

Conditions

Plaque Psoriasis

Interventions

DRUG

DSXS

active treatment

DRUG

Placebo

placebo treatment

Trial Locations (1)

10532

Taro Pharmaceuticals USA Inc., Hawthorne

All Listed Sponsors

lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT02618759 - Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis | Biotech Hunter | Biotech Hunter